DeepMed Research

RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Pembrolizumab in Treating Participants With Metastatic, Recurrent or Locally Advanced Cancer and Genomic Instability

Phase 2

Recruiting

Conditions: Metastatic Malignant Solid Neoplasm
Recurrent Malignant Solid Neoplasm
BRCA2 Gene Mutation
Stage IIIC Ovarian Cancer AJCC v8
Stage IV Ovarian Cancer AJCC v8
Locally Advanced Solid Neoplasm
Stage III Ovarian Cancer AJCC v8
Stage IIIA Breast Cancer AJCC v7
Stage IIIA Ovarian Cancer AJCC v8
Stage IV Breast Cancer AJCC v6 and v7

Interventions: Other: Laboratory Biomarker Analysis
Biological: Pembrolizumab

First Posted Date: 2018-02-12

Last Posted Date: 2022-11-18

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 40

Registration Number: NCT03428802

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York, United States

Resurgence as Choice: Basic and Clinical Studies

Not Applicable

Completed

Conditions: Problem Behavior
Self-injury
Communication

Interventions: Behavioral: Functional communication training

First Posted Date: 2018-02-06

Last Posted Date: 2023-08-21

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 17

Registration Number: NCT03423940

Locations: 🇺🇸
Rutgers University Center for Autism Research, Education, and Services, Somerset, New Jersey, United States

Examining Persistence in Smokers With Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia
Smoking Cessation
Schizo Affective Disorder

Interventions: Behavioral: counseling

First Posted Date: 2017-11-17

Last Posted Date: 2019-01-17

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 27

Registration Number: NCT03346291

Locations: 🇺🇸
Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Project HERO: Health Empowerment & Recovery Outcomes

Not Applicable

Completed

Conditions: Thyroid Cancer
Lung Cancer
Prostate Cancer
Rectum Cancer
Small Intestine Cancer
Soft Tissue Cancer
Colon Cancer
Bladder Cancer
Kidney Cancer

Interventions: Behavioral: Body Mind Training (BMT)
Behavioral: Usual Care (UC)

First Posted Date: 2017-11-17

Last Posted Date: 2025-01-27

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 114

Registration Number: NCT03345563

Locations: 🇺🇸
Rutgers University, New Brunswick, New Jersey, United States

Fiber Mix and Glycemic Response

Not Applicable

Completed

Conditions: Type2 Diabetes Mellitus

Interventions: Dietary Supplement: Fiber mix

First Posted Date: 2017-11-07

Last Posted Date: 2019-04-04

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 19

Registration Number: NCT03334643

Locations: 🇺🇸
Institute for Food, Nutrition & Health, New Brunswick, New Jersey, United States

Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project

Not Applicable

Completed

Conditions: Breast Cancer
Ovarian Cancer

Interventions: Behavioral: Mailed Targeted Print (TP)
Other: Usual Care (UC)
Behavioral: Telephone Counseling & Navigation (TCN)

First Posted Date: 2017-10-31

Last Posted Date: 2025-01-27

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 668

Registration Number: NCT03326713

Locations: 🇺🇸
Rutgers University, New Brunswick, New Jersey, United States

Modifying Young Adult Skin Cancer Risk and Protective Behaviors

Not Applicable

Completed

Conditions: Melanoma and Other Malignant Neoplasms of Skin

Interventions: Behavioral: UV4.me
Behavioral: E-Pamphlet
Behavioral: UV4.me2

First Posted Date: 2017-10-18

Last Posted Date: 2022-09-30

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 1746

Registration Number: NCT03313492

Locations: 🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Text Messaging Pilot Study

Not Applicable

Completed

Conditions: Literacy

Interventions: Behavioral: Intervention Group

First Posted Date: 2017-09-13

Last Posted Date: 2017-09-13

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 16

Registration Number: NCT03281356

Locations: 🇺🇸
Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Early Phase 1

Terminated

Conditions: Myelodysplastic Syndrome
Acute Lymphoblastic Leukemia
Acute Myeloid Leukemia in Remission
Hematopoietic Cell Transplantation Recipient
Non-Hodgkin Lymphoma
Plasma Cell Myeloma
Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma
Minimal Residual Disease
Recurrent Diffuse Large B-Cell Lymphoma
Recurrent Hematologic Malignancy

Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
Biological: Irradiated Allogeneic Cells

First Posted Date: 2017-09-05

Last Posted Date: 2023-06-26

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 2

Registration Number: NCT03272633

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer

Phase 2

Active, not recruiting

Conditions: Stage II Gastric Cancer AJCC v7
Stage IIIA Gastric Cancer AJCC v7
Stage IIIB Gastric Cancer AJCC v7
Epstein-Barr Virus Positive
Gastric Adenocarcinoma
Mismatch Repair Protein Deficiency
Stage IIA Gastric Cancer AJCC v7
Stage IB Gastric Cancer AJCC v7
Stage IIB Gastric Cancer AJCC v7
Stage III Gastric Cancer AJCC v7

Interventions: Drug: Capecitabine
Other: Laboratory Biomarker Analysis
Biological: Pembrolizumab
Radiation: Radiation Therapy

First Posted Date: 2017-08-22

Last Posted Date: 2025-04-16

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 40

Registration Number: NCT03257163

Locations: 🇺🇸
RWJBarnabas Health - Robert Wood Johnson University Hospital, Hamilton, Hamilton, New Jersey, United States
🇺🇸
Emory University, Atlanta, Georgia, United States
🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

and more 1 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy